Scientific Data of Functional Food
Reports of Recovery from Disease due to BRM4 - Cases 45-60
Please note that these reports make reference to MGN-3. BRM4 was previously sold under the name of
MGN-3 in the USA.
|
| |
| No. 45 Chronic C type virus hepatitis Facility/T
Hospital |
| Patient's name/T. Y AGE/56
years SEX/Female AREA/Hyogo Prefecture |
|
History of past diseases and treatments
In June 1997, screening of the patient revealed abnormal liver
function. As a result of a complete medical checkup, she was diagnosed with chronic C
type virus hepatitis. The idea of treating her with interferon was abandoned because
the treatment proved ineffective. There was fear that the disease would develop into
cirrhosis because of high viral concentrations although she had no symptoms of
fatigue and jaundice. However, no special treatment was available. Besides treatment
with a restricted diet and Chinese medicine, she was given MGN-3 3 g daily. Three
months after start of treatment, her GOT and GPT levels were 39 and 29, respectively.
Similar results were obtained in an examination performed after 6 months. Follow-up
care is necessary because viral concentrations remain at high levels although they
are decreasing.
Changes caused by ingestion of MGN-3
About 7 days after the start of MGN-3 therapy, fatigue began to
disappear. The patient felt her temperature rise and began to feel sleepy.
Evaluation of MGN-3
The action of MGN-3 to enhance immunopotency (activation of NK
cells and production of interferon) and protect the liver resulted in a decrease in
viral concentrations and mitigation of liver inflammation. Changes in subjective
symptoms after ingestion of MGN-3 seem to be manifestations of improvements in
immunopotency.
|
|
| No. 46 Chronic C type virus hepatitis Facility/T
Hospital |
| Patient's name/T. M AGE/60
years SEX/Male AREA/Shizuoka Prefecture |
|
History of past diseases and treatments
The patient began to feel malaise and tire in his lower limbs
in April 1996. These symptoms persisted so he visited a hospital in September to
undergo a complete medical checkup. Both the GOT and GPT levels were about 400
and he was diagnosed with C type virus hepatitis. He continued rest and dietary
therapy and began receiving treatment with interferon in June 1997. At this time
point, the GOT and GPT levels were both between 180 and 190. In addition to
interferon, the patient took MGN-3 3 g daily. He remained at the hospital for the
first 2 weeks of treatment with interferon. During this period, no adverse effect
was observed excepting a fever of 39?C or more. He treated with interferon
therapy for 6 months until late December by visiting the hospital 3 times weekly.
No adverse effect or attacks of fever occurred during this course except for
occasional fits of malaise associated with injection with interferon. The GOT and
GPT values were within the normal limits. Examinations in January and May, 1998,
revealed no viral reaction, showing complete remission. He is now taking MGN-3 2
g daily to prevent recurrence.
Changes caused by ingestion of MGN-3
Interferon is thought to have strong adverse effects such as
chills, anorexia and fever but the patient did not have serious adverse
effects.
Evaluation of MGN-3
The action of MGN-3 to enhance immunopotency and protect the
liver increased the effectiveness of interferon and resulted in complete recovery
from C type virus hepatitis without major adverse effects.
|
|
| No. 47 Articular rheumatism Facility/S Clinic |
| Patient's name/S. S AGE/25
years SEX/Female AREA/Kagoshima Prefecture |
|
History of past diseases and treatments
The patient felt chills in her limbs in early July 1997.
She attributed her chills to air conditioning and took care not to overcool
herself. Nevertheless, her limbs remained so cold as to become numb and she
never regained warmth. Meanwhile, her limbs began to swell and her joints
suddenly began to ache. In August, she visited this clinic for examination
because she became unable to get to sleep due to worsening pain. She was
diagnosed with articular rheumatism. In addition to analgesics,
electrothermotherapy and herbal medicine, she was given MGN-3 in increasing
doses starting from 1 g daily for the first 1 week to 2 g to 3 g. She was put
on a restricted diet that contained lower calories and less animal proteins
and more vegetables. The pain ameliorated in 1 week and she could use
analgesics in lower doses. After 1 month, swellings in her limbs and face
disappeared and joint pain began to subside. After 3 months, she felt much
less pain and was able to sleep soundly. In March 1998, the pain almost
disappeared and she recovered free movement of her middle fingers, which were
painful to bend.
Changes caused by ingestion of MGN-3
Three days after start of treatment with MGN-3, chills in
upper and lower limbs began to improve and she felt more warmth and less
pain.
Evaluation of MGN-3
The action of MGN-3 to normalize immunity improved symptoms
of articular rheumatism, which is an autoimmune disease.
|
|
| No. 48 Diabetes (NIDDM), asthma Facility/I
Clinic |
| Patient's name/K. N AGE/66
years SEX/Male AREA/Hyogo Prefecture |
|
History of past diseases and treatments
In June 1993, the patient had to get up a number of
times during the night for urination and had to drink water frequently to
satisfy thirst. He visited a hospital for examination and was diagnosed
with diabetes. The blood sugar level was 320 mg/dl. In September, he was
hospitalized and began to receive treatment. His blood sugar level did
not decrease until March 1994 and he was discharged because he developed
hepatopathy, a possible complication, and recovery was delayed. He
continued treatment with insulin injections by hospital visit but fatigue
did not disappear. He also had occasional attacks of asthma and felt
worse. At this time point, he began taking MGN-3 3 g daily. In May, 2
months after start of ingestion of MGN-3, the blood sugar level decreased
to 110 mg/dl and insulin was no longer necessary. Symptoms of asthma also
began to improve and he had no attack of asthma from the autumn of 1994
to the spring of 1995. He is now feeling better and working everyday. He
still takes MGN-3 1 g daily to maintain health.
Changes caused by ingestion of MGN-3
Seven days after start of ingestion of MGN-3, malaise
began to subside and the patient had a comfortable awakening. Symptoms of
asthma also ameliorated and the sense of incongruity in the throat
disappeared.
Evaluation of MGN-3
Treatment with MGN-3 that has the ability to improve
sugar metabolism and normalize immunity led to an improvement in
constitution and hence improvements in diabetes and asthma.
|
|
No. 49 Breast cancer and metastases in the brain
and lung
Facility/S Surgery |
| Patient's name/S.
K AGE/63
years SEX/Female AREA/Toyama Prefecture |
|
History of past diseases and treatments
On January 15, 1999, the patient presented with
severe headache and numbness in the right limbs at a nearby hospital
and was diagnosed with common cold. Her general condition worsened
and the right half of her body was paralyzed in late January. She
underwent examination at the brain surgery department of another
hospital and was found to have a brain tumor. Lung cancer and
metastases in lymph nodes were also discovered and the patient was
told she had only 3 months to live. She had undergone surgery for
breast cancer in 1989 so these diseases were considered recurrences
or metastases. She refused the chemotherapy recommended by the
hospital and was admitted to S Surgery, which provided complementary
medicine incorporating dietary, psychological and immune therapies.
She was given MGN-3 3 g daily as part of immunotherapy to activate NK
cells. The activity of NK cells increased to 52.6% 3 months after
start of treatment and all the tumors began shrinking. It is now 1
year and 6 months since she was told she had only 3 months to live
and she continues treatment with dietary therapy, qigong and MGN-3 3
g daily and is living a normal life.
Changes caused by ingestion of MGN-3
Ten days after start of treatment with MGN-3, the
patient began to recover appetite and her headache began to fade. She
became able to sleep soundly, felt physical strength improve and felt
more optimistic about here life.
Evaluation of MGN-3
MGN-3 seems to be playing a leading role as an
immunopotentiator in complementary medicine. The high level of
activity of NK cells indicates sufficient physical strength to resist
cancer. The patient is expected to maintain coexistence with cancer
until she fully recovers.
|
|
| No. 50 Oropharynx cancer Facility/S
Surgery |
| Patient's name/T.
H AGE/64 years SEX/Male AREA/Chiba
Prefecture |
|
History of past diseases and
treatments
In April 1998, the patient noticed a swelling
in the lymph node on the right side of his neck. He was having
his teeth treated so he thought this treatment caused the
swelling. Contrary to his supposition, the swelling in the lymph
node would not subside. He visited the National Cancer Center in
late May for a complete medical checkup and was diagnosed with
oropharynx cancer. The lesion grew to a size of 2.5 cm and the
patient was classified as stage 3 cancer. The doctor in charge
recommended a treatment regimen that involved trying radiotherapy
for 2 months and performing operation as required. Because the
patient feared adverse effects, he told the doctor that he would
choose alternative medicine and left the hospital. He began
treating himself but the disease advanced and he even had
difficulty speaking. In March 1999, he visited S Surgery.
Complementary medicine including immunotherapy and thermotherapy
was started in April. The patient was given MGN-3 3 g daily to
enhance immunity. After 2 weeks of hospitalization, the tumor
decreased to less than one third. He was discharged in late June
and has been on immunotherapy with vitamin B17 and MGN-3 by
visiting the hospital once a week. The UK activity increased from
7.4 at admission to 21.9 at discharge.
Changes caused by ingestion of
MGN-3
Seven days after start of ingestion of MGN-3,
the swelling in the mouth began to shrink and the patient found
speaking easier.
Evaluation of MGN-3
MGN-3 played a leading role as an
immunopotentiator in the systematic alternative/complementary
medicine of S Surgery and showed immediate effectiveness. The
tumor is expected to disappear as the NK activity
increases.
|
|
| No. 51 Stomach cancer
(scirrhous) Facility/S Surgery |
| Patient's name/K.
W AGE/54 years SEX/Male AREA/Hyogo
Prefecture |
|
History of past diseases and
treatments
In June 1998, the patient presented with
upset stomach at a nearby hospital but no abnormality was
found. Because the patient continued to feel incongruity in
his stomach, he visited a general hospital in late December
for reexamination. The result showed a scirrhous type stomach
cancer that is considered to have low success rates and he
was told that he had only 6 months to live. In February 1999,
he was admitted to S Surgery and received
alternative/complementary medicine including psychological,
dietary and immune therapies. He was given MGN-3 3 g daily as
part of immunotherapy. After hospitalization for 6 weeks
after hospitalization, his appetite improved and the activity
of NK cells increased from 7.5 at admission to 27.7. He was
discharged and is now convalescing at home. He has not yet
been rehabilitated but it is now 1 year since he was told he
had only 6 months to live.
Changes caused by ingestion of
MGN-3
Stomach pain began to subside 2 weeks after
start of treatment with MGN-3 and he felt physical strength
increasing.
Evaluation of MGN-3
A surprising fact is that most refractory
scirrhous type stomach cancer has been arrested. The
immunopotentiating action of MGN-3 must have been
responsible. The patient is expected to be in coexistence
with cancer as the NK cell activity increases.
|
|
| No. 52 Chronic hepatitis C, liver
cancer Facility/T Hospital |
| Patient's name/T.
K AGE/58
years SEX/Male AREA/Shizuoka
Prefecture |
|
History of past diseases and
treatments
The patient visited T Hospital in March
1998 for examination. The result showed that chronic
hepatitis C developed into cirrhosis and almost his
entire liver was invaded by liver cancer. The tumor
marker AFP was 281,000 and the GOT and GPT levels were 51
and 79, respectively. In addition to dietary therapy
mainly consisting of semi-fasting and thermotherapy, the
patient received MGN-3 3 g daily to enhance
immunopotency. The test results are shown
below.
Changes caused by ingestion of
MGN-3
Two weeks after start of ingestion of
MGN-3, the patient felt malaise begin to ameliorate and
became able to sleep soundly. Appetite also improved and
he even began to feel fasting painful.
Evaluation of MGN-3
The immunopotenciating action of MGN-3
seems to have helped the patient recover from terminal
liver cancer. This impressive case exemplifies
self-healing power and the power of MGN-3 that assists
it.
|
|
| No. 53 Chronic hepatitis C, liver
cancer Facility/O Clinic |
| Patient's name/T.
K AGE/66
years SEX/Female AREA/Osaka
Prefecture |
|
History of past diseases and
treatments
In 1990, the patient was diagnosed
with hepatitis C but had no special subjective
symptoms. In July 1995, a health checkup revealed an
abnormality in the liver and she had a complete
medical checkup at a general hospital, which revealed
a 3-cm liver cancer lesion. The treatment regimen
involved infusing ethanol into the affected area. The
patient was given MGN-3 3 g daily to reduce the
adverse effect of ethanol therapy and protect the
liver. Ethanol therapy was repeated 7 times but
adverse effects such as fever, nausea and anorexia
were mild. The AFP value also decreased from 602.5 to
7.2 so the patient was discharged on the last day of
September. Although the GOT and GPT values at
discharge were 60 and 85, respectively, the
examination of recurrence performed in February 1996
showed that the area treated with ethanol was
necrotized, the tumor disappeared completely and the
liver function normalized.
Changes caused by ingestion of
MGN-3
As early as 3 days after treatment
with MGN-3, the patient began to revive and regain
appetite. She felt she could endure ethanol therapy
with increased physical strength and wished to
recover complete health.
Evaluation of MGN-3
Ethanol therapy is performed to
solidify tumors with ethanol to prevent further
growth but may cause inflammations and pain in
surrounding tissues. The immunopotentiating effect
and liver-protection effect of MGN-3 reduced the
adverse effects of ethanol therapy and increased its
effectiveness.
|
|
| No. 54 Breast
cancer Facility/O Clinic |
| Patient's name/M.
O AGE/55
years SEX/Female AREA/Fukuoka
Prefecture |
|
History of past diseases and
treatments
In May 1997, a tumor was
detected in her right breast and metastases in
the lymph node were also observed. She was
immediately operated on. The operation was
successful but a monthly follow-up revealed a
suspected metastasis in the upper portion of her
left breast in July 1998. She was told that she
would take a complete medical checkup 3 weeks
later and then a treatment regimen would be
established. The patient immediately began taking
MGN-3 3 g daily to enhance immunity. After 3
weeks, workup by radiography and ultrasonography
revealed no tumor. She visited the hospital for
the following 2 months and was told she had
little chance of developing recurrent
diseases.
Changes caused by ingestion of
MGN-3
She was suffering headache and
malaise after the first operation but began to
feel headache and fatigue disappear after
treatment with MGN-3. She no longer felt
incongruity in her breasts about 1 week after
treatment.
Evaluation of
MGN-3
Increased NK cell activity by
MGN-3 enhanced overall self-healing ability and
caused the tumor to disappear. Breast cancer is
considered to recur within 2 years so maintaining
high postoperative immunopotency is important. In
these cases, MGN-3 seems to provide a potent
weapon.
|
|
| No. 55 Prostate
cancer Facility/C Cancer Center |
| Patient's
name/Y. M AGE/87
years SEX/Male AREA/Chiba
Prefecture |
|
History of past diseases and
treatments
In the year following 1993
when the patient barely survived cardiac
infarction, he had difficulty urinating and
visited C Cancer Center. He was diagnosed
with prostate cancer the size of a quail egg.
He underwent 2 courses of treatment
consisting of 1 week of chemotherapy with
anticancer drugs and 1 week of hormone
therapy. He was given MGN-3 3 g daily during
the course. As a result, the tumor marker PSA
decreased steadily and was within the normal
limits after completion of 2 courses. The
tumor disappeared almost completely. There
were few adverse effects and he lost only 2
kg. Thereafter, he was given anticancer drugs
and hormones regularly. In 1995, he felt
incongruity in his stomach and took a medical
checkup. The result showed 2 cancer lesions
at the bottom of the stomach. He was
immediately operated on and lost two-thirds
of his stomach. At the time, he received no
anticancer drug considering his age and
damage to the body. He began taking MGN-3
when he was returned to a normal diet. As of
May 2000, he shows no abnormal conditions and
the latest examination has revealed the
disappearance of old lesions of cardiac
infarction. There have been no recurrent
diseases of prostate cancer and stomach
cancer for 6 and 5 years,
respectively.
Changes caused by ingestion
of MGN-3
The patient took MGN-3 3 g
daily along with anticancer drugs and did not
lose appetite nor did he experience any
special adverse effect. In contrast, other
patients in the same room undergoing
treatment with the same anticancer drugs lost
appetite at the beginning of the second
course.
Evaluation of
MGN-3
The immunopotentiating
effect of MGN-3 complemented conventional
cancer treatment and led to remission. This
provides a valuable case. MGN-3 was shown to
be an essential material for improving QOL in
cancer treatment.
|
|
| No. 56 Articular
rheumatism Facility/I Clinic |
| Patient's
name/Y. S AGE/42
years SEX/Female AREA/Akita
Prefecture |
|
History of past diseases
and treatments
In early April 1997,
the patient noticed stiffness in her
fingers when getting up. Later, her
fingers began to swell and redden from
the base to the second joint and numbness
and stiffness spread to her wrists,
elbows and shoulders. In October, she had
pain and swellings in all joints
including heels and knees and had
difficulty walking. She visited an
orthopedist and was diagnosed with
rheumatism. Treatment with pain relievers
and thermotherapy was ineffective and she
was hospitalized because of a high fever
and the inability to walk due to
generalized pain. The symptoms somewhat
improved after 6 weeks of hospitalization
and she was discharged. In addition to
dietary therapy, she was given MGN-3 1 g
daily for a week and the dose was
increased to 3 g daily thereafter.
Stiffness was relieved from all joints 2
months after start of treatment with
MGN-3 and the deformation of fingers and
wrists improved after 3 months. Blood
test showed that she was negative for
rheumatic reaction.
Changes caused by
ingestion of MGN-3
The patient felt the
swellings in her finger joints subside 7
days after start of treatment with MGN-3
and felt her wrists, elbows and shoulders
move smoothly, which she had previously
felt too much pain to move.
Evaluation of
MGN-3
Rheumatism is an
autoimmune diseases arising from abnormal
functioning of immune cells. The action
of MGN-3 to normalize immune cells
normalized the immune system in a short
period and improved
rheumatism.
|
|
No. 57 Breast
cancer (metastasis in the left neck lymph
node)
Facility/T Clinic |
| Patient's name/M.
M AGE/48
years SEX/Female AREA/Aichi
Prefecture |
|
History of past
diseases and
treatments
The patient noticed
a swelling in her left neck lymph
node. She visited a nearby hospital
for a complete medical checkup, which
revealed a tumor in her left breast
and diagnosed the swelling in her
left neck as a metastatic lesion. She
was judged inoperable and put on
chemotherapy with 3 anticancer drugs
(Adriamycin, 5FU and
cyclophosphamide). The left breast
cancer involuted and the lymphatic
metastasis temporarily shrank.
Because the metastasis resumed
expanding and the tumor market did
not decrease, the patient received 4
sessions of chemotherapy. In January
2000, weekly infusion with docetaxel
wettable powder (Taxotere) was
started (until July) because there
were increases in lymphatic
metastasis and tumor maker values. On
January 18, the patient visited this
clinic because she desired
immunopotentiation therapy. On
January 28, she began to receive
massive infusion with vitamin C
(weekly) and Chinese medicine
(Hochuekkito 7.5 g/day) as well as
MGN-3 3 g/day (1 g at a time) as
immunopotentiation therapy. In June
the same year, shrinking of the lymph
swelling was confirmed. Hormone
therapy (progesterone preparation:
Hysron) replaced Taxotere in August.
Since then, no recurrence or
metastasis has been confirmed on
radiography, CT and ultrasonography
although tumor markers are
fluctuating.
Evaluation of
MGN-3
After the patient
began to take MGN-3 as part of
immunopotentiation therapy in
addition to chemotherapy, NK cell
activities increased and tumors
decreased in size. Eight months after
treatment with MGN-3, NK cell
activity increased more than 2-fold
and this increase seems to have
contributed to the prevention of
recurrence.
|
|
| No. 58 Rectum
cancer, bile duct
cancer Facility/T
Hospital |
| Patient's name/F.
Y AGE/68
years SEX/Female AREA/Shizuoka
Prefecture |
|
History of past
diseases and
treatments
In October
1995, the patient was examined
for occult blood in the stool and
the result was positive. A
complete medical checkup revealed
a cancer lesion that was so large
as to occlude the rectum. No
metastasis was detected. She
refused recommendations for
chemotherapy and was trying
immunotherapy on her own. In
November 1997, a metastatic
lesion was confirmed in the liver
and she underwent excision of 15%
of the liver and the gallbladder.
The patient began to visit this
hospital in April 1998 and she
was put on a restricted diet and
given supplements. After 1 year
of dietary therapy, she felt much
better and dietary therapy was
discontinued at her own request.
She stopped visiting the
hospital. About 1 year after the
discontinuation of treatment, the
patient noticed that her urine
was brown and had generalized
pain. She visited a nearby
hospital for examination. The
examination showed that her total
bilirubin was quite high and she
developed obstructive jaundice
due to metastatic bile duct
cancer, so she was immediately
hospitalized. A stent was
inserted first to expand the bile
duct. Another thicker stent was
inserted after 1 month. Jaundice
improved significantly but no
operation or radiotherapy was
performed for cancer at her
request. She received an
immunotherapeutic treatment of
this hospital for her cancer. She
was treated with a combination of
dietary therapy, an
immunopotentiator MGN-3 and other
health foods. MGN-3 was given in
a 7-day cycle of 4 successive
days of dosing at 7 g/day and 3
days of discontinuity. After
about 2 months of treatment with
immunotherapy, she no longer had
high fevers and the cancer
rapidly decreased in size. About
6 months after start of
immunotherapy, the cancer
disappeared.
Evaluation of
MGN-3
The bile duct
cancer was progressive and the
patient was recommended immediate
surgery and radiotherapy. She
chose a treatment that would
enhance self-healing potential in
consideration of QOL. MGN-3 was
used to play a leading part in
immunopotentiation and showed
effectiveness in a short period.
The tumor was eliminated because
overall spontaneous healing
capacity increased.
|
|
|
Patient's
name/H.
Y AGE/45
years SEX/Male AREA/Tochigi
Prefecture |
|
History of
past diseases and
treatments
In 1999,
the patient was found to have
a GOT and GPT levels of more
than 100 in a periodic health
examination. He had a
complete medical checkup and
was diagnosed with hepatitis
C. He knew he had lassitude.
He was recommended but
refused interferon therapy
for fear of adverse effects.
Regular injection with strong
Minophagen was the only
alternative treatment. After
6 months, the values of liver
function parameters increased
gradually. GOT increased to a
maximum of 215 and GPT to a
maximum of 408, so he began
to receive interferon
therapy. Before starting
interferon therapy, he was
given MGN-3 at 3 g/day and
put on a diet that centered
on vegetables for 1 month to
enhance immunopotency. After
1 month of MGN-3 treatment,
GOT and GPT were 20 and 28,
respectively. Thus,
interferon therapy was
cancelled. He continues
taking MGN-3 3 g daily and
the GOT and GPT levels are
within the normal
limits.
Evaluation
of MGN-3
The initial
treatment was ineffective
partly because he was in the
habit of smoking and
drinking. Because he gave up
smoking and drinking and
switched to a diet centering
on vegetables, MGN-3 had
immediate effect. The
immunopotentiating effect
(activation of NK cells,
production of interferon) and
liver-protecting effect of
MGN-3 resulted in a decrease
in the viral population and
elimination of liver
inflammation.
|
|
| No.
60 Hepatitis C→liver
cancer |
|
AGE/49
years SEX/Male Method
of ingesting
MGN-3/Immunotherapy |
|
History
of past diseases and
treatments
The
patient was a carrier of
hepatitis C virus and
diagnosed with liver
cancer. He had developed
a metastatic lesion in
the peritoneum (tumor
marker: 300,000) that was
untreatable. He switched
to a diet centering on
fresh vegetables and
began to take MGN-3 3
g/day (1 g/day). Six
months after start of
ingestion of MGN-3, the
tumor maker dropped to 15
and no cancer cells were
detected in the liver or
peritoneum.
Evaluation
of
MGN-3
Hepatitis C caused
liver cancer and
metastatic lesions were
observed in the
peritoneum. Although the
patient was considered
untreatable, 6 months of
strict diet and treatment
with an immunopotentiator
MGN-3 resulted in
elimination of cancer
cells.
|
|
|
|
